Minerva Biotechnologies
Kevin Yi has worked in the field of biotechnology since 2005. Kevin began their career as a Research Technician at Boston University School of Medicine in 2005. In 2006, they moved to MIT as a Research Technician II. In 2009, they joined Stemgent, Inc. as a Research Associate, and was later promoted to Senior Research Associate and Production and Quality Control Manager. In 2017, they began working as a Stem Cell Research Scientist for Minerva Biotechnologies.
Kevin Yi attended Boston University from 2001 to 2005, where they earned a Bachelor of Arts (B.A.) degree in Biology, General.
This person is not in any offices
Minerva Biotechnologies
Minerva Biotechnologies develops cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis.